|
|||||||||||||||||||||||||||||||||||||||||||||||
Table 7: Percentage (%) of patients in the study cohort with an ideal, underestimated, or overestimated dose of warfarin, as estimated with the IWPC pharmacogenetic algorithm and our pharmacogenetic algorithm (equation 2) in patients requiring low, intermediate, or high doses of warfarin for a therapeutic effecta. |